Which genes are involved in the glucose-uptake in skeletal muscle cells?4 answersExercise and various compounds like Estradiol Dipropionate (EDP), capsaicin, zinc, and Rac1 play crucial roles in regulating glucose uptake in skeletal muscle cells. Genes such as GLUT4, AMPK, PKC, Tiam1, and mechanosensitive GLUT6 are involved in this process. GLUT4 expression is promoted by EDP through AMPK and PKC signaling pathways. Exercise regulates the expression or phosphorylation of over 50% of glucose-uptake genes, including those not previously associated with insulin sensitivity. Capsaicin and zinc induce glucose uptake by activating calcium signaling molecules. Tiam1, part of an AMPK-Tiam1-Rac1 pathway, mediates contraction-stimulated glucose uptake in skeletal muscle. Interestingly, GLUT1 is not necessary for basal glucose uptake, suggesting a novel mechanism for overload-stimulated glucose uptake.
What is the endocrine interaction of adipose tissue with skeletal muscles?5 answersAdipose tissue and skeletal muscles have an endocrine interaction, with both tissues producing and releasing signaling molecules called adipokines and myokines, respectively. These molecules act in an autocrine, paracrine, and endocrine manner to regulate metabolic homeostasis and insulin sensitivity. Adipokines, such as adiponectin and leptin, can activate AMP-activated protein kinase and increase fatty acid oxidation in skeletal muscle, while myokines, such as IL-6, can stimulate lipolysis in adipose tissue. This cross-talk between adipose tissue and skeletal muscles plays a role in regulating energy metabolism, insulin resistance, and the development of metabolic disorders like obesity and type 2 diabetes. The interaction between these tissues is complex and involves various factors, including hormones, cytokines, and other regulatory molecules, which require further study to fully understand their physiological relevance.
How is brown adipose tissue glycogen metabolism regulated?4 answersBrown adipose tissue (BAT) glycogen metabolism is regulated through various mechanisms. One such mechanism involves the covalent modification of key glycogen-metabolic enzymes, protein turnover, and endocrine hormone signaling. Another regulatory factor is the lipoprotein lipase (LPL), which is controlled by angiopoietin-like 4 (ANGPTL4). Additionally, the carbohydrate response element binding protein (ChREBP) has been identified as a target gene in BAT that is upregulated by triiodothyronine (T3). Furthermore, the malate-aspartate shuttle (MAS) has been found to enhance thermogenesis, glucose uptake, and glycolysis in BAT. Finally, transplantation of BAT has been shown to improve glucose tolerance and insulin sensitivity, indicating a role for BAT in glucose homeostasis. These findings highlight the complex regulation of BAT glycogen metabolism and its importance in overall metabolic health.
How does insulin regulate adipose tissue?5 answersInsulin regulates adipose tissue by activating the insulin receptor (INSR), which consists of two isoforms: INSR-A and INSR-B. INSR-A is expressed in less-differentiated cells and has a mitogenic effect, while INSR-B is mostly expressed in adult tissues and has metabolic properties. The tissue-specific variation in INSR-A/INSR-B ratio can contribute to the development of metabolic abnormalities. Insulin also regulates the expression of clock genes in adipocytes and adipose-derived stem cells, suggesting a role in circadian clock regulation in adipose tissue. Insulin stimulates glucose uptake in adipose tissue by translocating glucose transporter 4 (GLUT4) from intracellular storage sites to the cell surface. This process involves the activation of PI3K and the phosphorylation of various proteins, including ATP-citrate lyase (ACL) and eukaryotic translation elongation factor 2 (eEF2). Insulin directly regulates circadian clocks in adipose tissue and isolated adipocytes, contributing to feeding-induced adipose tissue clock entrainment. Insulin also inhibits intracellular triglyceride lipolysis and regulates fatty acid esterification, glycerol and triglyceride synthesis, lipogenesis, and possibly oxidation in adipose tissue.
How does GLUT4 function in muscle and adipose cells?5 answersGLUT4 functions in muscle and adipose cells by facilitating the uptake of glucose from the bloodstream into these cells. In unstimulated muscle cells, GLUT4 is retained intracellularly, preventing glucose uptake. Upon stimulation by insulin or exercise, GLUT4 is translocated to the plasma membrane, allowing for increased glucose uptake. The regulation of GLUT4 involves its localization, efficient intracellular retention, and sensitivity to insulin and contraction. In muscle cells, AMPK promotes GLUT4 redistribution to the plasma membrane by regulating both exocytosis and endocytosis. Additionally, GLUT4 translocation involves redistribution of GLUT4 among different compartments within the cell, including the Trans Golgi Network Golgi compartments. The molecular mechanism of glucose transport by GLUT4 is still not fully understood, but studies have provided structural information on glucose transport and potential targets for therapeutic agents.
How are insulin-independent glucose transporters regulated?4 answersInsulin-independent glucose transporters are regulated through various mechanisms. In the context of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the down-regulation of glucose transporters GLUT4 and GLUT2 in vascular smooth muscle cells (VSMCs) leads to impaired glucose uptake. Insulin receptor signaling plays a crucial role in the translocation of glucose transporter GLUT4 to the plasma membrane, facilitating glucose uptake in adipose tissue and skeletal muscle. Caffeine has been shown to activate glucose transport by stimulating AMP-activated protein kinase (AMPK), a master regulator of insulin-independent glucose transport. In the kidney, sodium-glucose cotransporters (SGLT1 and SGLT2) are responsible for the reabsorption of glucose, while the facilitated glucose transporter GLUT2 is responsible for glucose efflux back into the blood. In critically ill patients, insulin therapy can regulate the expression of glucose transporters, such as upregulating GLUT4 in muscle and downregulating GLUT1 and GLUT3 in muscle and liver.